Torrent Pharmaceuticals Limited — Credit Ratings, 19-03-2025: Credit Rating

ICRA Limited has reaffirmed the long-term credit rating of Torrent Pharmaceuticals' banking facilities and non-convertible debentures at [ICRA] AA+ (Stable), alongside the existing ratings for its commercial paper program at [ICRA] A1+. This reaffirmation indicates strong financial health, driven by stable revenue streams and manageable debt levels, ensuring the company's robust position within the pharmaceutical sector. The stable outlook reflects ICRA's confidence in Torrent's ability to maintain its financial metrics amidst market fluctuations, which could lead to favorable borrowing costs. The rating action bolsters investor sentiment, highlighting the company's strategic resilience and potential for long-term growth, positioning it well for upcoming market opportunities.